Compare aXichem AB with Similar Stocks
Dashboard
1
With a growth in Operating Profit of 120.2%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 3 consecutive quarters
- NET SALES(HY) At SEK 8.41 MM has Grown at 343.85%
- OPERATING CASH FLOW(Y) Highest at SEK -11.34 MM
- NET PROFIT(HY) Higher at SEK -8.35 MM
2
Risky -
3
Market Beating Performance
Stock DNA
Specialty Chemicals
SEK 86 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.03
-33.37%
1.63
Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Dec 2025)
Net Profit:
-5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-27.23%
0%
-27.23%
6 Months
-53.91%
0%
-53.91%
1 Year
23.66%
0%
23.66%
2 Years
4.9%
0%
4.9%
3 Years
-77.28%
0%
-77.28%
4 Years
-92.1%
0%
-92.1%
5 Years
-95.62%
0%
-95.62%
aXichem AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
71.88%
EBIT Growth (5y)
-6.48%
EBIT to Interest (avg)
-10.19
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.14
Tax Ratio
0.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.90
EV to EBIT
-8.96
EV to EBITDA
-11.75
EV to Capital Employed
3.02
EV to Sales
14.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-33.68%
ROE (Latest)
-33.61%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
3.80
4.60
-17.39%
Operating Profit (PBDIT) excl Other Income
-3.80
-1.70
-123.53%
Interest
0.10
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.30
-3.10
-70.97%
Operating Profit Margin (Excl OI)
-1,324.00%
-644.00%
-68.00%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -17.39% vs -30.30% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -70.97% vs 8.82% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
18.40
8.60
113.95%
Operating Profit (PBDIT) excl Other Income
-12.00
-13.00
7.69%
Interest
0.10
2.00
-95.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-17.60
-17.80
1.12%
Operating Profit Margin (Excl OI)
-917.90%
-1,790.20%
87.23%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 113.95% vs 377.78% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 1.12% vs 14.42% in Dec 2024
About aXichem AB 
aXichem AB
Specialty Chemicals
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is a non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. The Company’s products comprise bio-repellents, feed ingredients, food and dietary supplements, which contain synthetically produced and patented capsaicin, traded as aXiphen. The Company’s shareholders are MANAKIN LTD, BLACK ARROW LTD and LMK VENTURES AB, among others.
Company Coordinates 
Company Details
Sodergatan 26 , MALMO None : 211 34
Registrar Details






